The purpose of the study is to examine the effect of Saxagliptin in the newly diagnosed people with pre-diabetes and obesity besides lifestyle intervention ,there to evaluate DPP 4 inhibitors of reversing pre-diabetes curative effect to normal blood sugar, and observe its influences on the targets of obesity related metabolic abnormalities, to explore new ways for intervention on populations with pre-diabetes and obesity .
Materials and Methods: This is a perspectiveness ,randomized, opening study, patients will be randomly assigned to the standarddose Saxagliptin group ,the lifestyle intervention group,the Metformin group and the low dose Saxagliptin group with a 6-month treatment period. Oral glucose tolerance test will examined before and 6 months post-treatment during the trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
5mg a day for 6 months
2.5 mg a day for 6 months
500mg three times a day for 6 months
Shandong Provincial Hospital
Jinan, Shandong, China
RECRUITINGoral glucose tolerance test
Time frame: Change of Blood sugar from baseline at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
lifestyle intervention for 6 months